InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
80%
T+90 mean return
+16.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MISSLING CHRISTOPHER U, Chairman & CEO. Insider active across 2 companies, notably ANAVEX LIFE SCIENCES CORP.. In total, 5 filings have been recorded. Activity tracked since 29 June 2021. The latest transaction was filed on 24 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations5 total
500,000 shares@ US$0.9241.6% of flowCommon StockSEC:0001731122-25-000452:0
73,380 shares@ US$1.328.8% of flowCommon StockSEC:0001731122-24-000552:0
268,000 shares@ US$1.6038.5% of flowCommon StockSEC:0001731122-23-001246:0
51,620 shares@ US$1.325.6% of flowCommon StockSEC:0001731122-21-001127
51,620 shares@ US$1.320.0074% mcap50.0% of flowCommon StockSEC:0001731122-21-001127:0
5 of 5 declarations
About MISSLING CHRISTOPHER U
Missling Christopher U is the Chief Executive Officer of Anavex Life Sciences Corp. In this role, he is responsible for the strategic direction and operations of the company. His experience in the biopharmaceutical sector enables him to lead innovative initiatives and foster Anavex's growth. He plays a key role in developing new therapies for patients.
